Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]

5951 reported adverse events

Drugs of this class: TEPROTUMUMAB

These side effects are most commonly reported by patients taking drugs of the Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] class:

# Side effect Count
0 MUSCLE SPASMS 1156
1 FATIGUE 822
2 TINNITUS 627
3 HYPOACUSIS 504
4 HEADACHE 499
5 DIARRHOEA 462
6 BLOOD GLUCOSE INCREASED 458
7 NAUSEA 453
8 ALOPECIA 441
9 ENDOCRINE OPHTHALMOPATHY 375
See all common reactions for Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]

Drugs of the Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEAFNESS PERMANENT 136 0.6939
1 ORBITAL DECOMPRESSION 14 0.6087
2 AUTOPHONY 34 0.4533
3 ENDOCRINE OPHTHALMOPATHY 375 0.4320
4 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 31 0.3875
5 TOXIC GOITRE 21 0.3443
6 EYELID RETRACTION 30 0.3000
7 ANTI-THYROID ANTIBODY INCREASED 17 0.1349
8 EXOPHTHALMOS 185 0.0859
9 POST PROCEDURAL HYPOTHYROIDISM 13 0.0613
See all enriched reactions for Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]